Menopause at 45: Is It Early?
How menopause differs from perimenopause, when hormone tests are useful and how age, symptoms and individual risks guide discussions about hormone therapy.

Menopause at 45 is at the lower end of the usual age range and is not classified as early menopause. Natural menopause generally occurs between 45 and 55, with an average age of about 51. Menopause before 45 is considered early; reduced ovarian function before 40 is referred to as premature ovarian insufficiency, or POI.
It is useful to distinguish perimenopause, early menopause, premature ovarian insufficiency and natural menopause. These are different situations, and the approach to assessment and care differs accordingly.
How does perimenopause differ from menopause?
Perimenopause is the transition before menopause and can last several years. Changes often begin after 40–45. Ovarian function does not stop overnight: ovulation gradually becomes less regular, and sex hormone production changes.
The first sign is often a change in the menstrual cycle. Cycles may become shorter or longer, periods may be delayed, and their duration or heaviness may change. A woman can still have periods while already being in perimenopause.
Other symptoms can include hot flushes, night sweats, sleep problems, mood changes, reduced libido, vaginal dryness, discomfort during sex and urinary symptoms. Their impact varies: some women experience a substantial effect on quality of life, while others notice very little.
When has menopause actually occurred?
Natural menopause is established after 12 consecutive months without a period when there is no other physiological or pathological explanation. It marks the final natural menstrual period and can only be identified retrospectively. A gap of two, three or even several months during perimenopause does not by itself establish that menopause has occurred.
Are FSH and other hormone tests needed after 45?
After 45, perimenopause is usually diagnosed clinically when symptoms and cycle changes are typical. Estradiol and follicle-stimulating hormone, or FSH, can fluctuate considerably during this time. An elevated FSH result may be much lower on a later test, so a single high result does not confirm menopause and a normal result does not rule out perimenopause.
Laboratory assessment becomes more relevant when cycle changes occur before 45. Women under 40 need particular attention to assess the possibility of premature ovarian insufficiency. Missing or changing periods should not automatically be attributed to age: depending on the clinical situation, pregnancy, thyroid conditions, hyperprolactinemia and other causes of irregular cycles need to be considered.
Why does the age at menopause matter?
The age at menopause matters for bone, cardiovascular and urogenital health. Earlier loss of ovarian function means a longer period of reduced estrogen stimulation. Early menopause, and especially premature ovarian insufficiency, therefore require attention even when hot flushes are not troublesome.
The timing of menopause reflects a combination of genetic and external factors. Family history can offer some guidance, including the age at which a woman's mother experienced menopause. Earlier loss of ovarian function can also be associated with smoking, certain autoimmune or genetic conditions, ovarian surgery, chemotherapy or radiotherapy, although an exact cause cannot always be identified.
When is menopausal hormone therapy considered?
Menopausal hormone therapy is considered according to symptoms and individual indications, rather than automatically after 45 or 50. The decision takes account of age, symptom severity, whether the uterus is present, bleeding patterns, personal and family history, other conditions and individual risks.
The main reasons to consider systemic treatment are troublesome vasomotor symptoms, including hot flushes and night sweats. Local vaginal treatment may be considered for urogenital symptoms such as marked vaginal dryness, burning or pain during sex. Treatment depends on the particular symptoms and clinical situation.
If the uterus is present, systemic estrogen must be accompanied by adequate endometrial protection with a progestogen. After removal of the uterus, a progestogen is usually unnecessary specifically for endometrial protection.
Premature ovarian insufficiency and early menopause are separate situations. In the absence of contraindications, hormone therapy is usually considered at least until the average age of natural menopause. Here, treatment addresses both symptoms and the replacement of hormonal function that would normally have continued for longer.
Can hormone therapy be used while periods continue?
Continuing to have periods is not in itself a contraindication to menopausal hormone therapy. A woman may be in perimenopause, still menstruating and experiencing symptoms that require treatment. However, the treatment regimen can differ from the one used after menopause.
Menopausal hormone therapy is not contraception. Pregnancy remains possible while ovulation can still occur, so contraception should be discussed separately when relevant.
What does menopause at 45 mean in practice?
Menopause at 45 falls at the lower end of the usual age range and is no longer classified as early. If cycles have only just started changing at 45, with delayed periods, hot flushes or sleep problems, this more often describes perimenopause than established menopause.
Assessment should not depend on one FSH or estradiol result. Age, the pattern of cycle changes, symptoms, medical history and the overall clinical picture determine whether further investigations or treatment are needed.
The clinic’s aesthetic gynecology page introduces its gynecological services. If nighttime waking is a concern, also read about what can prevent eight hours of uninterrupted sleep.
Author: Dr. Daria Fedorenko — Obstetrician-Gynecologist Specialist, Gynecological Endocrinology Specialist.